A 2022 cohort study analyzed weight loss outcomes in 175 people with obesity or overweight who were taking 1.7 mg or 2.4 mg of semaglutide for six months
The study found that the combined effect of getting enough sleep plus the A allele was associated with a reduced risk of hyperglycemia and high HbA1c
As an example of a combined GLP-1 + FIM intervention, eligible patients could receive both GLP-1 therapy and a FIM intervention emphasizing foods to support weight maintenance, reduce side effects, minimize loss of muscle and bone mass, and promote nutrient adequacy
For most, a gradual increase to the target dose maximizes benefits while minimizing side effects
Glucagon Glucagon, by contrast, is released when blood sugar is low
After 21 days at room temperature, discard regardless of expiration date